MUSTANG BIO, INC. Shareholders' Equity
MUSTANG BIO, INC. (MBIO) had Shareholders' Equity of $7.54 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-05
- 2026-06-30: Stockholders' Equity Attributable to Parent $7.54M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $8.60M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $9.53M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $9.77M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $7.54M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $8.60M 10-Q · filed 2026-08-05 |
| 2025-12-31 | $9.53M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $9.77M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $2.89M 10-Q · filed 2026-08-05 |
| 2025-03-31 | $3.61M 10-Q · filed 2026-08-05 |
| 2024-12-31 | -$3.87M 10-Q · filed 2026-08-05 |
| 2024-09-30 | -$8.66M 10-Q · filed 2025-11-07 |
| 2024-06-30 | -$8.33M 10-Q · filed 2025-11-07 |
| 2024-03-31 | -$4.94M 10-Q · filed 2025-08-08 |
| 2023-12-31 | $123.00K 10-K · filed 2026-03-19 |
| 2023-09-30 | $4.01M 10-Q · filed 2024-11-08 |
| 2023-06-30 | $13.71M 10-Q · filed 2024-11-08 |
| 2023-03-31 | $29.82M 10-Q · filed 2024-08-13 |
| 2022-12-31 | $46.27M 10-K · filed 2025-03-28 |
| 2022-09-30 | $64.33M 10-Q · filed 2023-11-14 |
| 2022-06-30 | $82.01M 10-Q · filed 2023-11-14 |
| 2022-03-31 | $97.33M 10-Q · filed 2023-08-14 |
| 2021-12-31 | $112.40M 10-K · filed 2024-03-11 |
| 2021-09-30 | $122.21M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $135.03M 10-Q · filed 2022-11-14 |
| 2021-03-31 | $133.36M 10-Q · filed 2022-08-11 |
| 2020-12-31 | $98.44M 10-K · filed 2023-03-30 |
| 2020-09-30 | $76.42M 10-Q · filed 2021-11-12 |
| 2020-06-30 | $71.03M 10-Q · filed 2021-11-12 |
| 2020-03-31 | $45.80M 10-Q · filed 2021-08-16 |
| 2019-12-31 | $51.65M 10-K · filed 2022-03-23 |
| 2019-09-30 | $62.45M 10-Q · filed 2020-11-06 |
| 2019-06-30 | $71.44M 10-Q · filed 2020-11-06 |
| 2019-03-31 | $28.48M 10-Q · filed 2020-08-10 |
| 2018-12-31 | $36.40M 10-K · filed 2021-03-24 |
| 2018-09-30 | $44.99M 10-Q · filed 2019-11-12 |
| 2018-06-30 | $51.60M 10-Q · filed 2019-11-12 |
| 2018-03-31 | $55.64M 10-Q · filed 2019-08-09 |
| 2017-12-31 | $59.83M 10-K · filed 2020-03-16 |
| 2017-09-30 | $65.09M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $69.07M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $74.21M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $24.28M 10-K · filed 2019-03-18 |
| 2016-09-30 | $3.32M 10-Q · filed 2016-11-14 |
| 2015-12-31 | -$4.13M 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |